Stock ROSSARI ROSSARI BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Rossari Biotech Limited Bombay S.E.

Equities

ROSSARI

INE02A801020

Specialty Chemicals

Market Closed - Bombay S.E.
Other stock markets
 03:30:47 10/05/2024 pm IST 		5-day change 1st Jan Change
714.6 INR +0.23% Intraday chart for Rossari Biotech Limited -1.61% -10.58%
01/05 Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 MT
30/04 Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024

Valuation

Fiscal Period: March 2021 2022 2023 2024 2025 2026
Capitalization 1 53,775 50,189 32,878 39,220 - -
Enterprise Value (EV) 1 52,876 50,189 32,878 37,399 39,220 39,220
P/E ratio 66.9 x 51.5 x 30.8 x 28.7 x 23.8 x 19.4 x
Yield 0.05% 0.05% 0.08% 0.43% 0.37% 0.7%
Capitalization / Revenue 7.58 x 3.38 x 1.99 x 2.04 x 1.88 x 1.61 x
EV / Revenue 7.58 x 3.38 x 1.99 x 2.04 x 1.88 x 1.61 x
EV / EBITDA 43.5 x 27.4 x 14.7 x 15 x 13.3 x 11.2 x
EV / FCF -521 x -566 x 27.5 x -315 x 72.8 x 28.6 x
FCF Yield -0.19% -0.18% 3.64% -0.32% 1.37% 3.5%
Price to Book 13.2 x 6.23 x 3.59 x 3.8 x 3.29 x 2.88 x
Nbr of stocks (in thousands) 51,929 55,056 55,155 55,247 - -
Reference price 2 1,036 911.6 596.1 709.9 709.9 709.9
Announcement Date 14/05/21 20/05/22 29/04/23 29/04/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,001 7,093 14,830 16,559 18,306 20,907 24,432
EBITDA 1 - 1,236 1,834 2,230 2,499 2,949 3,500
EBIT 1 - 1,008 1,354 1,601 1,895 2,214 2,698
Operating Margin - 14.21% 9.13% 9.67% 10.35% 10.59% 11.04%
Earnings before Tax (EBT) 1 - 1,068 1,363 1,442 1,776 2,173 2,676
Net income 1 - 802.2 976.7 1,073 1,307 1,645 2,016
Net margin - 11.31% 6.59% 6.48% 7.14% 7.87% 8.25%
EPS 2 - 15.47 17.70 19.38 23.62 29.80 36.53
Free Cash Flow 1 - -103.2 -88.67 1,195 -124.5 539 1,371
FCF margin - -1.45% -0.6% 7.22% -0.67% 2.58% 5.61%
FCF Conversion (EBITDA) - - - 53.59% - 18.28% 39.18%
FCF Conversion (Net income) - - - 111.43% - 32.77% 68.01%
Dividend per Share 2 - 0.5000 0.5000 0.5000 3.050 2.600 5.000
Announcement Date 01/10/20 14/05/21 20/05/22 29/04/23 29/04/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 2,182 2,311 3,845 4,284 4,389 4,347 4,254 3,893 4,065 4,106 4,392 4,718 4,843
EBITDA 1 352.1 371.2 439.7 469 523.1 577.3 565.4 541.6 545.8 577.5 623.5 629.5 654
EBIT 1 - - - - 357.7 424.1 409.1 382.1 - 436 454 467 494
Operating Margin - - - - 8.15% 9.76% 9.62% 9.81% - 10.62% 10.34% 9.9% 10.2%
Earnings before Tax (EBT) 1 - - - - 342.7 387 336.2 346.5 - 394.6 413 430 486
Net income 1 - 245.2 262.3 225.4 240.8 286.8 239.2 256.8 289.8 292.2 308 322 356
Net margin - 10.61% 6.82% 5.26% 5.49% 6.6% 5.62% 6.6% 7.13% 7.12% 7.01% 6.82% 7.35%
EPS 2 - - - - - - 4.320 4.630 - 5.280 5.600 5.800 6.600
Dividend per Share - - - - - - - - - - - - -
Announcement Date 14/05/21 30/07/21 30/10/21 14/02/22 20/05/22 06/08/22 05/11/22 04/02/23 29/04/23 29/07/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - 900 - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - -103 -88.7 1,195 -125 539 1,371
ROE (net income / shareholders' equity) - 23.1% 16.1% 12.5% 13.5% 14.7% 15.6%
ROA (Net income/ Total Assets) - - 10.7% 8.17% 9% 10.4% 11.4%
Assets 1 - - 9,090 13,121 14,696 15,814 17,684
Book Value Per Share 2 - 78.70 146.0 166.0 187.0 216.0 247.0
Cash Flow per Share - - - - - - -
Capex 1 - 581 382 329 967 1,762 635
Capex / Sales - 8.19% 2.58% 1.99% 5.24% 8.43% 2.6%
Announcement Date 01/10/20 14/05/21 20/05/22 29/04/23 29/04/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Rossari Biotech Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
709.9 INR
Average target price
862.3 INR
Spread / Average Target
+21.47%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

1st Jan change Capi.
ECOLAB INC. Stock Ecolab Inc.
+17.73% 66.69B
GIVAUDAN SA Stock Givaudan SA
+16.33% 41.24B
FUJIFILM HOLDINGS CORPORATION Stock Fujifilm Holdings Corporation
+18.68% 25.89B
EMS-CHEMIE HOLDING AG Stock EMS-CHEMIE HOLDING AG
+12.78% 19.81B
CELANESE CORPORATION Stock Celanese Corporation
+0.85% 17.48B
POSCO FUTURE M CO., LTD. Stock Posco Future M Co., Ltd.
-21.87% 15.86B
SYMRISE AG Stock Symrise AG
+2.32% 15.35B
ALBEMARLE CORPORATION Stock Albemarle Corporation
-10.29% 15.23B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A. Stock Sociedad Química y Minera de Chile S.A.
-22.30% 13.36B
Other Specialty Chemicals
  1. Stock Market
  2. Equities
  3. ROSSARI Stock
  4. ROSSARI Stock
  5. Financials Rossari Biotech Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW